Equine stem cell technique to be trialled in human medicine
15 April 2009
A pioneering equine stem cell technique, which is used to successfully return injured horses to top levels of performance, is to be trialled in human medicine. The trials will be conducted by MedCell Bioscience Ltd under the guidance of Dr David Glover, former medical director of Cambridge Antibody Technologies, Professor Nicola Maffulli, one of the most pre-eminent sports medicine and orthopaedic consultants in the UK and Roger Smith, Professor of Equine Orthopaedics at The Royal Veterinary College.
The repair technique was pioneered by surgeons at the Royal Veterinary College, who helped set up MedCell as a spin-out company.
Full story at MedCell Bioscience
Notes for editors
- The Royal Veterinary College is the UK's first and largest veterinary school and a constituent College of the University of London. In the recent Research Assessment Exercise the RVC ranked as England’s best school in the Agriculture, Veterinary and Food Science unit of assessment, for institutions whose research is exclusively veterinary related, with 55% of its submitted academics viewed as producing ’world class’ and ’internationally excellent’ research. The College provides support for veterinary and related professions through its three referral hospitals, diagnostic services and continuing professional development courses. www.rvc.ac.uk
Further Information
To request further information or an interview please contact:
- Hannah Murray on 01727 737997
email: hannah@communicationsmanagement.co.uk - Phil Smith on 01727 850761
email: phil@communicationsmanagement.co.uk
The Royal Veterinary College
Established in 1791, the RVC is the UK’s longest-standing veterinary college—with a proud heritage of innovation in veterinary science, clinical practice and education.